-

Vertellus to Acquire IM Chemicals, Expanding Its Specialty Solution Offerings

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus today announced that it has signed a definitive agreement to acquire ESIM Chemicals’ intermediates and specialties division (“IM Chemicals”), a leading provider of specialty chemical products serving the pharmaceutical, coatings, and fuel & lubricant markets. The transaction is subject to customary regulatory approvals.

Founded in 1857, Vertellus is a leading provider of specialty products for the healthcare, personal care, food & agriculture, coatings, and transportation markets. The company manufactures more than 700 products that are used in medical devices, vitamins, health & beauty applications, crop protection, and additives for fuel & lube applications. Vertellus serves customers across the globe from 10 manufacturing facilities located in the United States, United Kingdom, India, and China. Indianapolis-based Vertellus is owned by Pritzker Private Capital and management.

“This acquisition is directly in line with Vertellus’ strategy to become a leading global provider of specialty chemicals and solutions through both internal growth and acquisitions of complementary customer-focused businesses. We are excited to welcome the IM Chemicals team to the Vertellus family,” said John Van Hulle, CEO of Vertellus.

Jim Elliott, Vice President and General Manager of Vertellus’ Anhydrides & Specialties business, said “IM Chemicals is a perfect fit with Vertellus. The acquisition enhances our ability to meet the needs of our global customer base for specialized products and solutions, adding additional production capacities in Europe and expanding our product offerings into new markets.”

Thomas Chadwick, Principal at Pritzker Private Capital, added “The acquisition of IM Chemicals will expand Vertellus’ capabilities to deliver innovative specialty products and solutions to its customers. IM Chemicals is a strong fit with Vertellus’ strategy of using add-on acquisitions to accelerate growth in key markets, including health and beauty, coatings, specialty lubricants, as well as select food and crop protection markets.”

About Vertellus

Headquartered in Indianapolis, Indiana, the Vertellus group of companies was originally founded in 1857 as a manufacturer of niche specialty products. Today, Vertellus is a leading provider of unique specialty solutions used in the personal care, healthcare, coatings, transportation and food & agriculture markets. With 1000+ employees, Vertellus serves customers across the globe from its 10 international manufacturing facilities. Vertellus is a Responsible Care® company. For more information, visit vertellus.com.

About IM Chemicals

IM Chemicals is a leading producer of specialty anhydrides products used across a diverse group of end markets including coatings, pigments, construction and pharmaceutical. IM Chemicals operates a production site in Linz, Austria with more than 150 employees.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit www.ppcpartners.com.

Contacts

Media:
Abernathy MacGregor
Dan Scorpio
(312) 640-3111
dps@abmac.com

Vertellus


Release Versions

Contacts

Media:
Abernathy MacGregor
Dan Scorpio
(312) 640-3111
dps@abmac.com

More News From Vertellus

Aurorium Names Faye Freeman Chief Executive Officer

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, today announced that Faye Freeman, currently the company’s President, has been appointed Chief Executive Officer. Ms. Freeman, who joined Aurorium in 2019, will succeed John Van Hulle, who will transition to the role of Executive Chairman. “Faye is a fantastic leader with a proven track record of commercial and operational excellence,” said Mr. Van Hulle. “I’ve worked closely with her...

Aurorium Launches Haelium™ Pharmaceutical Solutions

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions. This new brand reflects Aurorium’s passion for and long-term commitment to healthcare. Built on decades of innovation, the Haelium product line unifies Aurorium as a global leader in pharmaceutical ingredients. Inspired by the Old English word “hælan," which meant “to cure,” “save,” or “make whole,” the Haelium br...

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus, a leading global supplier of high-performance solutions to the medical industry, is showcasing its range of Citroflex™ B6 phthalate free plasticizers, Biothane™ adhesives and sealants and PC Technology™-powered hemocompatible surface coatings at leading medical device expo MD&M West in Anaheim, Calif. Vertellus will be located at Booth 1289 at the Anaheim Convention Center from April 12 to April 14. “We look forward to sharing our high-quality speci...
Back to Newsroom